Interestingly, this is somewhat in contrast to our previous findings in cholangiocarcinoma with FGFR2 fusions, in which we found that quisinostat can upregulate the activation of FGFR and Erk signaling28. The gene discussed is FGFR2; the disease is cholangiocarcinoma.